StockData
GRDXNasdaqElectric & Other Services CombinedFiscal year ends December 31

GridAI Technologies Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Sep 18, 2026
$4.39+0.17 (+4.03%)

Close on Oct 19, 2026

Market cap
$23.23T
P/E (TTM)
–
Dividend yield
–

About GridAI Technologies

Electric & Other Services Combined, SIC 4931

GridAI Technologies Corp. is a diversified technology and biopharmaceutical company operating across two main areas: energy orchestration software and legacy biopharmaceutical development. Through its subsidiary Grid AI Corp., the company develops energy infrastructure optimization software and an artificial intelligence data center platform designed to manage distributed energy resources, such as battery energy storage systems, on-site generation, and grid interconnections. The subsidiary also maintains legacy front-of-meter load-shaping and residential home energy management platforms. In life sciences, the company conducts research on Adrulipase, an oral recombinant enzyme therapy intended to treat exocrine pancreatic insufficiency. Prospective customers for the energy platform include AI data center developers, hyperscalers, and energy infrastructure developers, alongside ongoing discussions with battery storage providers.

The company operates across North America and Australia, where it is pursuing market opportunities and pilot deployments, while also re-evaluating distributed energy management in the United Kingdom. Corporate headquarters details are not specified in the text.

Summary of the business section of GridAI Technologies's latest annual report, written by StockData.

Company profile

Company

Legal name
GridAI Technologies Corp.
Founded
2014
Headquarters
Boca Raton, FL
Address
433 Plaza Real, Suite 275
Phone
(561) 589-7020
Employees
2, Dec 31, 2025
Industry
Electric & Other Services Combined
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Macias Gini & OConnell LLP, Irvine, CA

Stock & identifiers

Ticker
GRDX
Exchange
Nasdaq
IPO date
Oct 13, 2016
Shares outstanding
7M, Aug 21, 2026
Public float
$14.90M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-3 reverse, Aug 18, 2025; 1-for-3 reverse, Aug 18, 2025; 1-for-20 reverse, Dec 18, 2023; 1-for-7 reverse, Jan 18, 2023; 1-for-30 reverse, Sep 30, 2022; 1-for-30 reverse, Aug 26, 2022; 2472721-for-1, Mar 31, 2022; 1-for-10 reverse, Sep 13, 2021
SEC CIK
1604191
CUSIP
33749P507
ISIN
US33749P5070
LEI
549300I3YKRXWGWPG039
EIN
46-4993860

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Jason David SawyerChief Executive Officer, Director540,000
Richard PaoloneInterim CEO, Director–
Anna SkowronInterim CFO65,000
Sarah RomanoChief Financial Officer17,287
Jack SyageDirector55,400
Edward BorkowskiDirector73,928
Manpreet UppalDirector40,000
Geordan Garrett PursgloveDirector40,000
Eric CorbettDirector–

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2024
James Sapirstein
$510.31K$510.31K$451.36K$-0–
FY2023
James Sapirstein
$1.25M$671.31K$810.56K$-28–
FY2022
James Sapirstein
$741.72K$184.27K$389.87K$-48–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 2 full-time employees at the parent company level.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 14, 2026Late filingNotification of late filing
May 15, 2026Late filingNotification of late filing
Apr 28, 2026Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Mar 31, 2026Late filingNotification of late filing
Jan 7, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Nov 19, 2025Name changeName changed from Entero Therapeutics, Inc. to GridAI Technologies Corp.
Nov 17, 2025Late filingNotification of late filing
Oct 6, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 14, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Apr 1, 2025Late filingNotification of late filing
Mar 7, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jan 13, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Sep 11, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 29, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
Aug 23, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 15, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
Aug 15, 2024Late filingNotification of late filing
Aug 7, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jun 5, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
May 16, 2024Name changeName changed from First Wave BioPharma, Inc. to Entero Therapeutics, Inc.
Mar 22, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Mar 14, 2024Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 31, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 25, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 18, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Dec 16, 2022Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 25, 2022Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jul 15, 2022Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jul 7, 2022Auditor changeChange in certifying accountant (8-K Item 4.01)
May 27, 2022Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)